期刊文献+

Roche Cobas E411电化学发光分析仪检测降钙素原的分析前质量控制 被引量:2

下载PDF
导出
摘要 目的对Roche Cobas E411电化学发光分析仪检测降钙素原(PCT)过程分析前的几个主要影响因素进行质量控制。方法采用Roche Cobas E411电化学发光分析仪分别对患者进食后1h内、输液过程中、溶血、脂血、带抗凝剂的血液标本进行检测,检测过程严格按照仪器操作标准程序进行,对照为自身对照。结果患者进食后1h内与空腹血液样结果无显著差异;输液过程中的检测结果与空腹结果有显著差异;溶血、血脂标本对测定结果有影响;带抗凝剂的血液标本与普通生化管测定结果有显著差异。结论 Roche Cobas E411电化学发光分析仪检测降钙素原(PCT)分析前的几个主要影响因素出进食外对测定结果均造成干扰,在检测过程中需严格的质量控制。
出处 《中国医药指南》 2013年第10期658-659,共2页 Guide of China Medicine
  • 相关文献

参考文献3

二级参考文献19

  • 1[1]Karzai W, Oberhoffer M, Meier-hellmann A, et al. Procalcitonin-A new indicater of the systemic response to severe infections. Infection, 1997, 25:329.
  • 2[2]Ggendrel D, Assicot M, Raymond S, et al. Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr, 1996,128:570.
  • 3[3]Whang KT, Steinwald PM, White JC. et al. Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab, 1998,83 : 3692.
  • 4[4]Nylen ES, Snider RH Jr, Thompson KA, et al. Pneumonitis associated hyperprocalcitoninemia. Am J Med Sci, 1996,321:12.
  • 5[5]Gendrel D, Raymond J, Assicot M, et al. Measurement of procalcitonin levels in childern with bacterial or viral meningitis. Clin Infect Dis, 1997,24:1240.
  • 6[6]Eberhard OK, Haubitz M, Brunkhorst FM, et al. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus crythematosus/systemic antineutrophil cytoplasmic antibody-associated vaseulitis) and invasive bacterial infection. Arthritis Rheum,1997,40:1250.
  • 7[2]Brunkhorst FM,Wegscheider K,Forychi ZF,et al.Procalcitonin for early diagnosis and differentiation of SIRS,sepsis,severe sepsis,and septic shock[J].Intensive Care Med,2000,26(Suppl 2):148-152.
  • 8[3]Eberhard OK,Langefeld I,Kuse ER,et al.Procalcitonin in the early phase after renal transplantation -will it add to diagnostic accuracy[J]? Clin Transplant,1998,12(3):206-211 .
  • 9[4]Brunkhorst FM,Eberhard OK,Brunkhorst R,et al.Discrimination of infectious and non-infectious causes of early acute respiratory distress syndrome by procalcitonin[J].Crit Care Med,1999,27(10):2172-2176.
  • 10[5]American College of Chest Phsicians/Society of Critical Care Medicine Consensus Conference:Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J].Crit Care Med,1992,20(6):864-874.

共引文献61

同被引文献13

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部